宽QRS高心率:当冲击无效时,扩大您的视野
Claudio Mario Ciampi1, Giovanni Malanchini2
1School of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
Journal of electrocardiology
|May 9, 2025
概括
腺素反应对于诊断节律性宽QRS高心率至关重要. 了解这种心电图的发现可以在任何情况下改善患者的护理.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 宽QRS心动减速 presents诊断上的挑战.
- 氨酸是一种抗失律药物,具有特定的电生理学效应.
研究的目的:
- 突出阿诺辛反应在宽QRS高心率中的重要性.
- 强调在各种临床环境中腺素的诊断效用.
主要方法:
- 对具有挑战性的ECG进行案例研究分析.
- 对与腺素相关的电生理学原理的审查.
主要成果:
- 氨酸的使用可以区分各种广泛的QRS心动节拍.
- 对腺的特定反应提供了关键的诊断线索.
结论:
- 腺素响应是节奏宽QRS高心率的重要诊断工具.
- 临床医生应该考虑阿诺辛在管理这些心律失常方面的作用.
更多相关视频
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
14.4K
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.1K
相关概念视频
01:28Disturbances in Heart Rhythm
721
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
721
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
823
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
823
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
648
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
648
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
692
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
692
01:30Cardiac Action Potential
594
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
594
01:26Heart Failure Drugs: Inotropic Agents
416
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
416